Found 6 matching trials
A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed
PHASE1This is a Phase 1, open-label study of HMPL-689 administered orally to pati...
Location
TongJi Medical College Huazhong University of Science& Technology
A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma
PHASE2A phase II clinical study of tazemetostat combined with HMPL-689 in patient...
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
A Study of HMPL-689 in Healthy Volunteers
PHASE1The purpose of this study is to evaluate the safety and tolerability of a s...
Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas
PHASE1An open-label, dose escalation and expansion clinical trial to evaluate the...
Location
Innovative Clinical Research Institute
HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI
PHASE1An open-label study to determine effect of Itraconazole, Fluconazole, Rifam...
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
PHASE2A Multi-center, Single-arm, Open-label Clinical Study to Evaluate the Effic...
Location
The Second Hospital of Anhui Medical University